Morgan Stanley to Delist the Biotech BOXES(SM) and the Pharmaceutical BOXES(SM) From...

Morgan Stanley to Delist the Biotech BOXES(SM) and the Pharmaceutical BOXES(SM) From NASDAQ OMX PHLX

Withdrawal Results from Exchange's Decision to Terminate Its
Equity Trading Platform
NEW YORK--(Business Wire)--
Morgan Stanley (NYSE:MS) announced today its intention to
voluntarily delist the following securities as a result of the
decision of NASDAQ OMX PHLX, formerly the Philadelphia Stock Exchange,
to terminate its equity trading platform effective October 24, 2008:

-- Biotech BOXES(SM) due January 30, 2032, Basket Opportunity
eXchangeablE Securities(SM) Exchangeable for a Cash Amount
Based on the Closing Prices of the Underlying Stocks of the
AMEX BIOTECHNOLOGY INDEX (CUSIP: 61744Y413)

-- Pharmaceutical BOXES(SM) due October 30, 2031, Basket
Opportunity eXchangeablE Securities(SM) Exchangeable for a
Cash Amount Based on the Closing Prices of the Underlying
Stocks of the AMEX EQUAL WEIGHTED PHARMACEUTICAL INDEX (CUSIP:
61744Y520)

Shares of the Biotech BOXES(SM) and the Pharmaceutical BOXES(SM)
will continue to be traded on the American Stock Exchange (AMEX) under
ticker symbols "BXB" and "RXB," respectively, until the listing is
transferred to NYSE Arca effective November 24, 2008 in connection
with NYSE Euronext's acquisition of AMEX.

Morgan Stanley is a leading global financial services firm
providing a wide range of investment banking, securities, investment
management and wealth management services. The Firm's employees serve
clients worldwide including corporations, governments, institutions
and individuals from more than 600 offices in 35 countries. For
further information about Morgan Stanley, please visit
www.morganstanley.com.

Media Relations:
Morgan Stanley
Carissa Ramirez, 212-762-6834

Copyright Business Wire 2008